Bracket completes EXACT e-Diary Certification program on Android smartphone and tablet

NewsGuard 100/100 Score

Bracket, one of the industry's leading eCOA solutions providers today announced that it has completed the e-Diary Certification program with Evidera™ for the EXACT patient daily e-Diary on both an Android smartphone, and an Android Tablet. The certification allows Bracket to standardize its EXACT e-Diary eCOA solution and pass valuable delivery efficiencies to clinical trial sponsors or contract research organizations (CRO). This is an important milestone as it demonstrates Bracket eCOA solution as it becomes the first and only provider of this instrument to be certified on a tablet device.

The EXACT (the EXAcerbations of Chronic pulmonary disease Tool) is a 14-item patient reported outcome (PRO) daily diary used to quantify and measure exacerbations of chronic obstructive pulmonary disease (COPD). Exacerbations are events characterized by an acute, sustained worsening in the patient's COPD beyond normal day-to-day variability, including an increase in respiratory symptoms such as dyspnea, cough, and sputum production that may require a change in treatment. The EXACT e-Diary is designed to standardize the assessment of the patient's condition in order to capture this dynamic process.

"Today's eCOA landscape is very promising," says Jim Primerano, Senior Vice President and GM, eClinical at Bracket. "The use of ePRO and eCOA solutions in clinical trials has grown in the past 2 years and Bracket sees immense value in providing validated outcomes instruments to facilitate the collection of key trial data. We are very pleased to incorporate the EXACT e-Diary into our ePRO library of instruments, extending more efficiency in delivery of eCOA solutions to our customers."

Source:

Bracket

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New model predicts kidney injury risk in cancer patients on cisplatin